Exploring BMI and Metabolic Health in Neurology

This chapter examines Body Mass Index (BMI) as a crucial measure in assessing obesity, particularly in relation to GLP-1 receptor agonists for patients with idiopathic intracranial hypertension. It highlights the limitations of BMI in reflecting true body composition and discusses metabolic improvements that extend beyond simple weight loss.